These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38779592)

  • 1. A lipid nanoparticle platform incorporating trehalose glycolipid for exceptional mRNA vaccine safety.
    Bae SH; Yoo S; Lee J; Park HJ; Kwon SP; Jin H; Park SI; Lee YS; Bang YJ; Roh G; Lee S; Youn SB; Kim IW; Oh HR; El-Damasy AK; Keum G; Kim H; Youn H; Nam JH; Bang EK
    Bioact Mater; 2024 Aug; 38():486-498. PubMed ID: 38779592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid nanoparticle-based mRNA candidates elicit potent T cell responses.
    Zeng Y; Escalona-Rayo O; Knol R; Kros A; Slütter B
    Biomater Sci; 2023 Jan; 11(3):964-974. PubMed ID: 36537916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of ionizable lipid tail length on lipid nanoparticle delivery of mRNA of varying length.
    Mrksich K; Padilla MS; Joseph RA; Han EL; Kim D; Palanki R; Xu J; Mitchell MJ
    J Biomed Mater Res A; 2024 Sep; 112(9):1494-1505. PubMed ID: 38487970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid nanoparticle composition for adjuvant formulation modulates disease after influenza virus infection in quadrivalent influenza vaccine vaccinated mice.
    Jangra S; Lamoot A; Singh G; Laghlali G; Chen Y; Ye T; García-Sastre A; De Geest BG; Schotsaert M
    Front Immunol; 2024; 15():1370564. PubMed ID: 38711520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability.
    Schoenmaker L; Witzigmann D; Kulkarni JA; Verbeke R; Kersten G; Jiskoot W; Crommelin DJA
    Int J Pharm; 2021 May; 601():120586. PubMed ID: 33839230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Ketal-Ester Ionizable Lipid Nanoparticle with Reduced Hepatotoxicity, Enhanced Spleen Tropism for mRNA Vaccine Delivery.
    Lv K; Yu Z; Wang J; Li N; Wang A; Xue T; Wang Q; Shi Y; Han L; Qin W; Gong J; Song H; Zhang T; Chang C; Chen H; Zhong X; Ding J; Chen R; Liu M; Zhang W; Cen S; Dong Y
    Adv Sci (Weinh); 2024 Dec; 11(45):e2404684. PubMed ID: 39387241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemistry of Lipid Nanoparticles for RNA Delivery.
    Eygeris Y; Gupta M; Kim J; Sahay G
    Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Expression Kinetics and Immunogenicity of Lipid Nanoparticles Delivering Plasmid DNA and mRNA in Mice.
    Zhang W; Pfeifle A; Lansdell C; Frahm G; Cecillon J; Tamming L; Gravel C; Gao J; Thulasi Raman SN; Wang L; Sauve S; Rosu-Myles M; Li X; Johnston MJW
    Vaccines (Basel); 2023 Oct; 11(10):. PubMed ID: 37896985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Synergistic Lipid Nanoparticle Encapsulating mRNA Shingles Vaccine Induces Potent Immune Responses and Protects Guinea Pigs from Viral Challenges.
    Cheng X; Liu S; Sun J; Liu L; Ma X; Li J; Fan B; Yang C; Zhao Y; Liu S; Wen Y; Li W; Sun S; Mi S; Huo H; Miao L; Pan H; Cui X; Lin J; Lu X
    Adv Mater; 2024 Mar; 36(13):e2310886. PubMed ID: 38145557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations into mRNA Lipid Nanoparticles Shelf-Life Stability under Nonfrozen Conditions.
    Reinhart AG; Osterwald A; Ringler P; Leiser Y; Lauer ME; Martin RE; Ullmer C; Schumacher F; Korn C; Keller M
    Mol Pharm; 2023 Dec; 20(12):6492-6503. PubMed ID: 37975733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of lipid nanoparticles for mRNA vaccines by the machine learning algorithm.
    Wang W; Feng S; Ye Z; Gao H; Lin J; Ouyang D
    Acta Pharm Sin B; 2022 Jun; 12(6):2950-2962. PubMed ID: 35755271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fluorinated ionizable lipid improves the mRNA delivery efficiency of lipid nanoparticles.
    Huo H; Cheng X; Xu J; Lin J; Chen N; Lu X
    J Mater Chem B; 2023 May; 11(19):4171-4180. PubMed ID: 37129135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding structure activity relationships of Good HEPES lipids for lipid nanoparticle mRNA vaccine applications.
    Goldman RL; Vittala Murthy NT; Northen TP; Balakrishnan A; Chivukula S; Danz H; Tibbitts T; Dias A; Vargas J; Cooper D; Gopani H; Beaulieu A; Kalnin KV; Plitnik T; Karmakar S; Dasari R; Landis R; Karve S; DeRosa F
    Biomaterials; 2023 Oct; 301():122243. PubMed ID: 37480759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme-Catalyzed One-Step Synthesis of Ionizable Cationic Lipids for Lipid Nanoparticle-Based mRNA COVID-19 Vaccines.
    Li Z; Zhang XQ; Ho W; Li F; Gao M; Bai X; Xu X
    ACS Nano; 2022 Nov; 16(11):18936-18950. PubMed ID: 36269150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases.
    Pilkington EH; Suys EJA; Trevaskis NL; Wheatley AK; Zukancic D; Algarni A; Al-Wassiti H; Davis TP; Pouton CW; Kent SJ; Truong NP
    Acta Biomater; 2021 Sep; 131():16-40. PubMed ID: 34153512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine.
    Muramatsu H; Lam K; Bajusz C; Laczkó D; Karikó K; Schreiner P; Martin A; Lutwyche P; Heyes J; Pardi N
    Mol Ther; 2022 May; 30(5):1941-1951. PubMed ID: 35131437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
    Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
    Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration.
    Carrasco MJ; Alishetty S; Alameh MG; Said H; Wright L; Paige M; Soliman O; Weissman D; Cleveland TE; Grishaev A; Buschmann MD
    Commun Biol; 2021 Aug; 4(1):956. PubMed ID: 34381159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing.
    El-Mayta R; Padilla MS; Billingsley MM; Han X; Mitchell MJ
    J Vis Exp; 2023 Jan; (191):. PubMed ID: 36744791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening.
    Guimaraes PPG; Zhang R; Spektor R; Tan M; Chung A; Billingsley MM; El-Mayta R; Riley RS; Wang L; Wilson JM; Mitchell MJ
    J Control Release; 2019 Dec; 316():404-417. PubMed ID: 31678653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.